23 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
to oversee particular projects or activities (e.g., development and/or manufacturing). Each Subcommittee will consist of a mutually agreed number
424B5
7jle67vuo3o08l 56
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
2jqeswxn59
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
co7tawebfqa5flc34
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm